Evaluation of the Safety & Performance of LiNiDERM® in the Prevention of

Status Completed

Clinical Trial Summary

Result of immaturity of the skin and factors promoting maceration and mechanical interactions, Irritant diaper dermatitis (IDD) can manifest as early as the third week of life. IDD is a form of contact dermatitis and is the most common inflammatory dermatitis of the diaper area infants. This dermatitis is very common amongst first year of life.

The IDD is characterized by erythema on the convex surfaces with the skin folds spared (W-shaped erythema) and it can cause considerable pain and stress for infants and can be troublesome for their caregivers.

The development of IDD is multifactorial. The critical step in the development of IDD is the occlusion of the skin under the diaper. The skin in the diaper area is predisposed to irritation by the presence of urine, stool, friction on the skin and presence of a high skin pH (potential Hydrogen).

At the cellular level, there is a gradual disorganization of the lipid layers and later an attack of keratinocytes. Clinically, maceration is followed by an inflammatory reaction.

Hence, infrequent diaper changes create overhydration and maceration of the stratum corneum, which makes the skin more sensitive to friction; this may interfere with the protective barrier function, allowing for the exposure of the lower layers to irritants (mechanical, chemical and infectious).

The removal of maceration and the reduction of friction are the key to prevention. But it is recommended to respect preventive measures, in order to preserve the normal skin condition over the long term. Special care procedures are required to ensure healthy development and to protect the skin from irritation and inflammation, as well as a sense of well-being. Although use of appropriately formulated cleansers and emollients can help maintain the epidermal skin barrier in the diaper region, good hygiene and adequate protection are necessary to prevent skin barrier breakdown, rash and infection. The prevention of IDD includes frequent diaper changing, parent education and cleaning.

LiNiRASH is a monocentric, prospective, randomized, comparator controlled study conducted under paediatric control. 132 infants will be followed in this study for 4 weeks during which their parents will use a specific cleaning method: water and cotton pads or wipes or liniment. The objective of this study is to compare the performance and safety of this 3 cleaning methods on the prevention of infant diaper rash.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Diaper Rash

Clinical Trial Details

NCT number	NCT03640897
Study type	Interventional
Source	Laboratoires Gilbert
Contact
Status	Completed
Phase	N/A
Start date	August 2, 2018
Completion date	March 18, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02893501` - Infant Microbiome in Diaper Rash	N/A
Completed	`NCT05328232` - The Effect Of Olive Oil on Diaper Rash	N/A
Completed	`NCT02996357` - Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence	N/A
Completed	`NCT05427760` - Effect Of Using Oxygen On The Diaper Dermatitis In Infants	N/A
Completed	`NCT03685929` - Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis
Completed	`NCT05599763` - Multicenter, National, Observational, Prospective, Real-life Study Evaluating the Performance of 2% Aqueous Eosin in Children With Diaper Rash
Completed	`NCT03309059` - Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly	N/A
Terminated	`NCT02475512` - Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly	N/A
Completed	`NCT00702507` - Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants	Phase 4
Completed	`NCT03138057` - BM Characterization Pilot	N/A
Withdrawn	`NCT03425851` - Diaper Distribution in Low-Income Infants	N/A
Completed	`NCT00219466` - Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash	Phase 4
Withdrawn	`NCT01167465` - Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis	Phase 4
Completed	`NCT04210674` - Effects of Argan Spinosa Oil in the Treatment of Diaper Dermatitis in Infants and Toddlers	N/A
Terminated	`NCT02299206` - CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants	N/A
Completed	`NCT06015217` - A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash	Phase 4
Withdrawn	`NCT05471180` - Adjuvant Effect of Photobiomodulation in the Treatment of Incontinence-associated Dermatitis in Adults	N/A
Completed	`NCT05892081` - Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms